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Abstract
Introduction: Campylobacter species represent the main cause of bacterial diarrhea in developed countries and
one of the most frequent causes of enterocolitis in developing ones. In some patients, Campylobacter jejuni
infection of the gastrointestinal tract has been observed as an antecedent illness of acute motor axonal
neuropathy, a variant of Guillain-Barré syndrome.
Case presentation: We present a case of acute motor axonal neuropathy following infection with Campylobacter
jejuni subspecies jejuni, biotype II, heat stable serotype O:19. A 46-year-old Caucasian man developed acute motor
neuropathy 10 days after mild intestinal infection. The proximal and distal muscle weakness of his upper and lower
extremities was associated with serum antibodies to Campylobacter jejuni and antibodies to ganglioside GM1. The
electromyographic signs of neuropathic muscle action potentials with almost normal nerve conduction velocities
indicated axonal neuropathy. Our patient’s clinical and electrophysiological features fulfilled criteria for the
diagnosis of an acute motor axonal neuropathy, a subtype of Guillain-Barré syndrome.
Conclusion: As this is the first case of acute motor axonal neuropathy following infection with Campylobacter
jejuni subspecies jejuni reported from the Balkan area, the present findings indicate the need for systematic studies
and further clinical, epidemiological and microbiological investigations on the prevalence of Campylobacter jejuni
and its heat stable serotypes in the etiology of Guillain-Barré syndrome and other post-infectious sequelae.
Introduction
Campylobacter jejuni has been recognized as one of the
most common causes of bacterial diarrheal illness in
humans [1]. After C. jejuni infection, severe post-infec-
tious sequelae may occur, such as post-infectious acute
motor axonal neuropathy (AMAN), a subtype of Guil-
lain-Barré syndrome (GBS) [2].
The clinical entity ‘GBS’ can be divided into three
forms: acute inflammatory demyelinating polyneuropa-
thy (AIDP), which has as its main characteristic feature
the macrophage-mediated demyelination of the periph-
eral nerves; axonal pattern, with axonal involvement,
consisting of AMAN; and rare acute motor-sensory axo-
nal neuropathy (AMSAN). AIDP and AMAN are differ-
entiated by their clinical, electrophysiological and
serological manifestations [2]. Miller Fisher syndrome
(MFS), a variant of GBS, is characterized by
ophthalmoplegia, ataxia and areflexia. Conditions related
to MFS are Bickerstaff’s brainstem encephalitis (BBE)
(ataxia and impaired consciousness, with or without
ophthalmoplegia, and areflexia or hyporeflexia); acute
ophthalmoparesis (extraocular muscle paralysis arising
in the absence of ataxia or areflexia); ataxic GBS (which
m a yb ea t a x i cG B S ,s e n s o r ya t a x i cG B Sa n dp u r es e n -
sory GBS in which ataxia is the dominant clinical fea-
ture, in the absence of either limb or craniopharyngeal
weakness); and pharyngeal-cervical-brachial (PCB) weak-
ness (oropharyngeal, neck and shoulder weakness in the
absence of significant limb weakness, with facial palsy,
blepharoptosis, absence of sensory disturbance and pre-
served tendon jerk in the legs) [2]. Some authors con-
sider PCB, GBS, MFS and BBE to be forms of a
continuous spectrum [3].
Studies have shown that lipopolysaccharides extracted
from C. jejuni associated with GBS mimic human gang-
liosides in their structure [2]. Moreover, patients with
GBS triggered by C. jejuni infection usually have more
* Correspondence: biljams@eunet.rs
1Department of Microbiology and Immunology, School of Medicine,
University of Niš, Bul Dr Z Đinđića, 81, 18000 Niš, Serbia
Miljković-Selimović et al. Journal of Medical Case Reports 2010, 4:101
http://www.jmedicalcasereports.com/content/4/1/101 JOURNAL OF MEDICAL
CASE REPORTS
© 2010 Miljković-Selimović et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.severe disease than those triggered by other microorgan-
isms [4].
Serotyping based on heat stable (HS) antigens [5] is
the preferred method for the investigation of the clonal-
ity of bacterial strains related to post-infectious poly-
neuropathies. Some HS C. jejuni serotypes such as HS
O:19 are usually associated with GBS. HS serotypes
observed in other GBS patients include O:1; O:2; O:4;
O:4 complex (4, 13, 16, 43, 50); O:5; O:10; O:16; O:23;
O:37; O:41; O:44 [6], and O:35 and O:13/65 [7].
There is a lack of evidence on the prevalence of C.
jejuni in many geographical areas including Serbia as a
triggering organism in the etiology of GBS and other
post-infectious sequelae. In addition, there is a lack of
evidence on serotype distribution and GBS associated
strains for some geographical areas.
We present a case of AMAN, a subtype of GBS, fol-
lowing infection with C. jejuni subspecies jejuni, biotype
II O:19. According to our knowledge, this is the first
report of AMAN associated with C. jejuni in the Balkan
region.
Case presentation
A 46-year-old Caucasian man, a physician from a town
in central Serbia, had nausea, fever, and had suffered
watery diarrhea that lasted for one day. The diarrhea
was self-limiting and he was treated only with antipyre-
tic drugs. Ten days later, he felt muscle weakness in
both upper and lower extremities. Proximal weakness in
his arms resulted in difficulty in lifting them above his
shoulders, and in his legs in difficulty climbing stairs
and rising from a low chair. During the following days
weakness also appeared in his distal arm muscles, and
gradually increased in his upper and lower leg muscles
until our patient became severely disabled. Three days
prior to admission, our patient complained of muscular
pain in both his legs, low back and shoulders.
On admission, seven days after the first symptoms
occurred, our patient’s mental status was normal and
cranial nerves were not affected. Both nerves innervating
the proximal and distal muscle groups were affected in
the upper and lower extremities resulting in symmetric
proximal and distal muscle weakness which ranged
between 3 and 4 on the Medical Research Council
(MRC) grading scale. Deep tendon reflexes were normal,
with the exception of both triceps brachii reflexes which
were abolished. Pathological reflexes were also absent.
There was no sensory nerve dysfunction and no sphinc-
ter disturbances (Quantitative Sensory Testing, Semmes-
Weinstein monofilament, 128 Hz tuning fork).
Electrophysiological investigation was performed three
weeks after the beginning of the first symptoms. Electro-
myography (EMG) revealed polyphasic neuropathic
muscle action potentials with reduced interference
pattern and compensatory motor unit potentials in the
proximal and distal muscles of his upper and lower
extremities. The amplitude of motor evoked potentials
was slightly reduced for both peroneal and right med-
iana and for the ulnar nerve. Motor and sensory con-
duction velocities were normal.
The following laboratory examinations were normal:
blood sedimentation rate, complete blood count, blood
glucose, serum electrolytes, urea nitrogen, creatinine,
serum protein content, cholesterol, triglycerides, and
liver and muscle enzymes. The protein level in the cere-
brospinal fluid (CSF) was measured seven days after the
beginning of muscle weakness and was slightly elevated
at 0.59 g/L. According to laboratory standards, a normal
upper limit is 0.46 g/L. Cell count was normal with 3
mononuclear cells/mm
3. A normal cell value is less than
10 cells/mm
3.
In view of a probable diagnosis of AMAN, our patient
received from the first day of hospitalization a course of
intravenous immunoglobulin (IVIG) at the standard
dose of 0.4 g/kg/day: a daily dose of 30 g was admini-
strated over a period of five days (our patient’sw e i g h t
was 75 kg). IVIG resulted in an immediate dramatic
improvement. From the 11th day after his admission, in
view of the positive stool cultures for C. jejuni (see
below), he received 1500 mg of oral erythromycin daily
in order to eradicate antigenic stimuli. On his 24th day
of hospitalization, our patient’s neurological status
improved with residual mild weakness of the foot dorsi-
flexor muscles and minimal weakness of the proximal
and distal muscles of his arms. Three weeks later he
had no muscle weakness and his tendon reflexes were
brisk.
Because of the clinical signs and the history of a pre-
ceding gastrointestinal infection, a stool sample was sent
to the Republic Institute of Public Health, Belgrade, for
microbiological examination. For the detection of ther-
mophilic campylobacters the Columbia agar base was
supplemented with 5% sheep blood and antibiotics
(cefoperazone 1.5 g/L, colistin 106 U, vancomycin 1 g/L,
amphotericin B 0.2 g/L), (bioMérieux, Marcy l’Etoile,
France). Culture was incubated at 42°C for 48 hours in
a microaerophilic atmosphere (biomérieux). Fortunately,
due to a delay in sampling, the primary culture was seen
as positive for Campylobacter, and the subculture of
solid plate yielded a confluent growth of colonies typical
for Campylobacter, which were oxidase- and catalase-
positive with a characteristic microscopic appearance,
with S-shaped and curved rods. Identification, biotyping
and serotyping were performed at the Bacteriology and
Enteric Disease Program, National Microbiology Labora-
tory, Winnipeg, Manitoba, Canada. A strain presump-
tively identified as Campylobacter was differentiated to
the species level by a combination of biotyping tests [8]
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restriction fragment length polymorphism (RFLP) test
[9]. Heat stable serotyping was performed using Penner’s
method [5]. The strain was identified as C. jejuni sub-
species jejuni biotype II HS O:19, sensitive to
erythromycin.
Antibodies to C. jejuni were determined by indirect
immunofluorescence assay using as antigen methanol-
fixed whole bacteria of the C. jejuni. Five pools, each
consisting of 50 sera of healthy blood donors, were used
as controls.
Autoantibodies to peripheral nerve gangliosides,
including monosialoganglioside (GM1), disialoganglio-
side (GD1a) and asialoganglioside (ASGM1) were deter-
mined by enzyme-linked immunosorbent assay (ELISA),
using methanol-fixed antigen-coated 96-well micro-
ELISA plates and peroxidase-conjugated secondary anti-
immunoglobulin G (IgG) and immunoglobulin M (IgM)
goat antibodies.
On the day of the admission, serum antibodies to C.
jejuni were positive in a titer of 1:128, while the control
s e r ah a dt i t e r so fu pt o1 : 8 .O nd a y2 4 ,t h ea n t i b o d y
titers were still positive at 1:32. The IgG anti-GM1 anti-
bodies were positive in the first serum sample (day 4) in
a significant titer (1:16,000, with negative controls 1:400)
and changed to negative (1:400) on days 10 and 19 after
admission. There was no serum reactivity against gang-
liosides GD1a and ASGM1.
Discussion
So far, there have been no reports about the incidence
of such cases in Serbia. The neurological signs of a per-
ipheral neuropathy, the history of a preceding gastroin-
testinal infection, the isolation of C. jejuni serotype O:19
from the patient’s stool and the positive IgG anti-GM1
antibodies are typical of a C. jejuni-associated GBS. In
the present case, electrophysiological findings indicated
axonal neuropathy which was in accordance with ante-
cedent C. jejuni infection and positive anti-GM1 antibo-
dies, and in combination with neurological finding was
compatible with the diagnosis of AMAN.
Although GBS is characterized by areflexia, particu-
larly in patients with severe flaccid paralysis, in the pre-
sent case reflexes were retained (apart from in the
triceps). In patients with mild and moderate muscle
weakness with preserved active movement deep tendon
r e f l e x e sm a yb el o s ti ns o m eb u tn o ta l lm u s c l eg r o u p s .
Some occasional cases with unusually brisk deep tendon
reflexes have been reported [10].
Serological finding of anti-campylobacter antibodies,
supporting results obtained by cultivation, and the find-
ing of anti-ganglioside antibodies completed the picture
of possible cross-reactivity as the mechanism of axonal
lesion. Indeed, the role of anti-GM1 antibodies in GBS
has been extensively investigated [11]. An experimental
animal model of GBS induced by inoculation of GM1
ganglioside confirms the role of anti-GM1 antibodies in
the immunopathogenesis of GBS [12]. Patients with
AMAN and negative anti-GM1 antibodies may have
antibodies to peripheral nerve myelin glycoprotein
cross-reactive with GM1 [13].
Although our patient recovered without complications,
GBS is not a mild disease. Population-based studies
show mortality of approximately 10%, and a require-
ment for artificial ventilation in approximately 25% of
cases [14].
Concerning the bacteriological diagnosis of a C. Jejuni-
associated GBS, a lag time of 1-3 weeks between campy-
lobacter infection and the onset of GBS must be taken
into account. In our particular case, AMAN occurred 10
days after the onset of the campylobacter infection. C.
jejuni was recovered in the sample taken on day 31 after
the onset of diarrheal disease. Further excretion of micro-
organisms was not examined. For the recovery of the
strain, only selective solid medium was used. Bacteria
were present in the small sample, and sub-cultivation
produced a pure culture and characteristic growth.
Consistent reports on the prevalence and characteriza-
tion of thermophilic campylobacter strains isolated from
all over the world are yet to be combined globally for
research purposes. The characterization of thermophilic
campylobacter strains is not necessary for routine diag-
nostic procedures since the disease is often mild and
self-limited, and free of complications. However, some
characteristics of clinical presentations, such as chronic
post-infectious sequelae, are related to certain HS sero-
types which may vary by geographical area; and the epi-
demiology of campylobacter-associated GBS cannot be
determined without the use of typing schemes.
Conclusion
Campylobacter jejuni enterocolitis was diagnosed in our
patient with the AMAN form of GBS, suggesting a close
association between the bacterial infection and the
severe acute neuropathy, supporting the general hypoth-
esis of cross-reactivity between bacteria and human per-
ipheral neural tissue. After the administration of therapy
including an antibacterial drug, our patient recovered
fully despite the general poor prognosis in a case of
campylobacter post-infectious sequelae. Indeed, besides
neurological examinations, specific microbiological and
immunological examinations are needed for etiological
GBS diagnosis. As this is the first case of AMAN follow-
ing infection with C. jejuni subspecies jejuni,r e p o r t e d
from Serbia, further clinical, epidemiological and micro-
biological investigations on the prevalence of C. jejuni
and its HS serotypes in the etiology of GBS and other
post-infectious sequelae are warranted.
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